However, most insurance companies do not cover these medications if they are prescribed for weight loss, such as Wegovy, Saxenda or Ozempic (off-label)
Interestingly, Saxendas United States patent is set to expire, and generic versions of this medication MAY be available as early as June of 2024
GLP-1 receptors in the arcuate nucleus and other hypothalamic areas are essential for appetite control
As an antioxidant, coenzyme Q10 protects our cells from harmful free radicals
Smaller, observational clinical experiences and case reports suggest some patients may tolerate concurrent use, but these anecdotal accounts cannot substitute for rigorous trial data
Generic medications can vary in size, color, and shape between orders depending on the manufacturer